Home
ProMab Biotechnologies Inc

ProMab Biotechnologies Inc Market Share Analysis for November 2025

ProMab Biotechnologies CAR T-cell Expansion Medium (FBS, fetal bovine serum) optimized for expansion of CAR T-cells 100-fold greater than normal media.

Science and Education > Biology

Domainpromab.com

Year Founded2001

Employees51 - 200

Annual Revenue$5M - $10M

ProMab Biotechnologies Inc

ProMab Biotechnologies Inc (including company regionals)

promab.com

See more website traffic and engagement information

ProMab Biotechnologies Inc Revenue up to November 2025 is 5M - 10M

revenue generated by ProMab Biotechnologies Inc top domains

ProMab Biotechnologies Inc top domains revenue over 3 years

Revenue for ProMab Biotechnologies Inc top domains

promab.com5M - 10M

See more with Sales Intelligence

Total visits to ProMab Biotechnologies Inc's top domains

Understand ProMab Biotechnologies Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

promab.com6.4K

See more with Sales Intelligence

Avg. visit duration in ProMab Biotechnologies Inc's top domains

Analyze ProMab Biotechnologies Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

promab.com00:01:32

See more with Sales Intelligence

Avg. pageviews on ProMab Biotechnologies Inc's top domains

See how ProMab Biotechnologies Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

promab.com2.94

See more with Sales Intelligence

ProMab Biotechnologies Inc top competitors by domain

Top similar sites in November 2025, ranked by their affinity

stemcell.comCompany NameSTEMCELL TechnologiesEmployees1001 - 5000HQCanada, VancouverAnnual revenue$200M - $500MTotal visits261.5KScience and Education > Biology

Top technologies used by ProMab Biotechnologies Inc

These are the website technologies, by industry, used by ProMab Biotechnologies Inc top domains

Advertising (7)

DoubleClick

eCommerce (6)

Shopify

Conversion & Analytics (5)

Google Analytics

Email Services (5)

G Suite

More Technologies

9

See all

News & Signals from ProMab Biotechnologies Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsProMab Biotechnologies, Inc. is developing novel antibody and chimeric antigen receptor T-cell therapy for hematological malignancies.The company has collaboration agreement with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy for hematological malignancies, as well as a collaborative research agreement with Affilogic to assess proprietary anti-tumor targeting agents in combination with DOS47.

NewsProMab Biotechnologies, Inc. is developing novel immunotherapy for multiple myeloma.NantKwest and ProMab Biotechnologies are collaborating to develop a novel immunotherapy for multiple myeloma using natural killer (NK) cells that target the B-cell maturation antigen, or BCMA.